| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A DNA vaccine encoding a peptide mimic of Streptococcus pneumoniae serotype 4 capsular polysaccharide induces specific anti-carbohydrate antibodies in Balb/c mice
|
Lesinski, Gregory B
|
|
2001
|
19 |
13-14 |
p. 1717-1726
10 p.
|
artikel
|
| 2 |
Antibody responses to pneumococcal and haemophilus vaccinations in patients with B-cell chronic lymphocytic leukaemia
|
Hartkamp, A
|
|
2001
|
19 |
13-14 |
p. 1671-1677
7 p.
|
artikel
|
| 3 |
Antibody to the nonstructural protein NS1 of Japanese encephalitis virus: potential application of mAb-based indirect ELISA to differentiate infection from vaccination
|
Shu, Pei-Yun
|
|
2001
|
19 |
13-14 |
p. 1753-1763
11 p.
|
artikel
|
| 4 |
Current status and future trends in vaccine regulation — USA
|
Falk, Lydia A.
|
|
2001
|
19 |
13-14 |
p. 1567-1572
6 p.
|
artikel
|
| 5 |
Cytokine responses to human immunodeficiency virus type 1 (HIV-1) induced by immunization with live recombinant canarypox virus vaccine expressing HIV-1 genes boosted by HIV-1SF-2 recombinant GP120
|
Gorse, Geoffrey J.
|
|
2001
|
19 |
13-14 |
p. 1806-1819
14 p.
|
artikel
|
| 6 |
Design, characterization and preclinical efficacy of a cationic lipid adjuvant for influenza split vaccine
|
Guy, Bruno
|
|
2001
|
19 |
13-14 |
p. 1794-1805
12 p.
|
artikel
|
| 7 |
Detoxification of endotoxin by aluminum hydroxide adjuvant
|
Shi, Yi
|
|
2001
|
19 |
13-14 |
p. 1747-1752
6 p.
|
artikel
|
| 8 |
Early commitment of adoptively transferred CD4+ T cells following particle-mediated DNA vaccination: implications for the study of immunomodulation
|
Creusot, Rémi J.
|
|
2001
|
19 |
13-14 |
p. 1678-1687
10 p.
|
artikel
|
| 9 |
Effects of intranasal administration of cholera toxin (or Escherichia coli heat-labile enterotoxin) B subunits supplemented with a trace amount of the holotoxin on the brain
|
Hagiwara, Yukari
|
|
2001
|
19 |
13-14 |
p. 1652-1660
9 p.
|
artikel
|
| 10 |
Electric pulses increase the immunogenicity of an influenza DNA vaccine injected intramuscularly in the mouse
|
Bachy, Monique
|
|
2001
|
19 |
13-14 |
p. 1688-1693
6 p.
|
artikel
|
| 11 |
Ensuring vaccine safety in immunization programmes — a WHO perspective
|
Jodar, L
|
|
2001
|
19 |
13-14 |
p. 1594-1605
12 p.
|
artikel
|
| 12 |
Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals
|
Peeters, Ben P.H.
|
|
2001
|
19 |
13-14 |
p. 1616-1627
12 p.
|
artikel
|
| 13 |
Humoral and cell-mediated immune responses of foxes (Vulpes vulpes) after experimental primary and secondary oral vaccination using SAG2 and V-RG vaccines
|
Lambot, M
|
|
2001
|
19 |
13-14 |
p. 1827-1835
9 p.
|
artikel
|
| 14 |
Immunisation with DNA encoding Leishmania infantum protein papLe22 decreases the frequency of parasitemic episodes in infected hamsters
|
Fragaki, Konstantina
|
|
2001
|
19 |
13-14 |
p. 1701-1709
9 p.
|
artikel
|
| 15 |
Immunization-related products: introduction to the panel discussion
|
Milstien, Julie B.
|
|
2001
|
19 |
13-14 |
p. 1592-1593
2 p.
|
artikel
|
| 16 |
Immunization with plasmid DNA expressing the caprine arthritis–encephalitis virus envelope gene: quantitative and qualitative aspects of antibody response to viral surface glycoprotein
|
Beyer, J.C
|
|
2001
|
19 |
13-14 |
p. 1643-1651
9 p.
|
artikel
|
| 17 |
Immunological analyses of human papillomavirus capsids
|
Giroglou, Tzenan
|
|
2001
|
19 |
13-14 |
p. 1783-1793
11 p.
|
artikel
|
| 18 |
Key drivers behind the development of global vaccine market
|
Gréco, Michel
|
|
2001
|
19 |
13-14 |
p. 1606-1610
5 p.
|
artikel
|
| 19 |
Licensing IP to ensure accessibility to vaccines and other immunisation-related products
|
Mehta, J.M.
|
|
2001
|
19 |
13-14 |
p. 1581-1587
7 p.
|
artikel
|
| 20 |
Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype
|
Nöjd, Johan
|
|
2001
|
19 |
13-14 |
p. 1727-1731
5 p.
|
artikel
|
| 21 |
Novel use of anaerobically induced promoter, dmsA, for controlled expression of fragment C of tetanus toxin in live attenuated Salmonella enterica serovar Typhi strain CVD 908-htrA
|
Orr, Nadav
|
|
2001
|
19 |
13-14 |
p. 1694-1700
7 p.
|
artikel
|
| 22 |
Oligonucleotide containing CpG motifs enhances immune response to mucosally or systemically administered tetanus toxoid
|
Eastcott, Jean W
|
|
2001
|
19 |
13-14 |
p. 1636-1642
7 p.
|
artikel
|
| 23 |
Oral transgene vaccination mediated by attenuated Salmonellae is an effective method to prevent Herpes simplex virus-2 induced disease in mice
|
Fló, Juan
|
|
2001
|
19 |
13-14 |
p. 1772-1782
11 p.
|
artikel
|
| 24 |
Prevention of vertical transmission of Neospora caninum in BALB/c mice by recombinant vaccinia virus carrying NcSRS2 gene
|
Nishikawa, Yoshifumi
|
|
2001
|
19 |
13-14 |
p. 1710-1716
7 p.
|
artikel
|
| 25 |
Product development plan for new vaccine technologies
|
Ellis, Ronald W
|
|
2001
|
19 |
13-14 |
p. 1559-1566
8 p.
|
artikel
|
| 26 |
Reduction of recurrent HSV disease using imiquimod alone or combined with a glycoprotein vaccine
|
Harrison, Christopher J
|
|
2001
|
19 |
13-14 |
p. 1820-1826
7 p.
|
artikel
|
| 27 |
Safety and immunogenicity of ALVAC wild-type human p53 (vCP207) by the intravenous route in rhesus macaques
|
Rosenwirth, Brigitte
|
|
2001
|
19 |
13-14 |
p. 1661-1670
10 p.
|
artikel
|
| 28 |
Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans
|
Treanor, John J.
|
|
2001
|
19 |
13-14 |
p. 1732-1737
6 p.
|
artikel
|
| 29 |
Site-directed mutation in a conserved kinase domain of human cytomegalovirus-pp65 with preservation of cytotoxic T lymphocyte targeting
|
Yao, Zhi-Qiang
|
|
2001
|
19 |
13-14 |
p. 1628-1635
8 p.
|
artikel
|
| 30 |
Th1 genetic adjuvants modulate immune responses in neonates
|
Pertmer, Tamera M.
|
|
2001
|
19 |
13-14 |
p. 1764-1771
8 p.
|
artikel
|
| 31 |
Two B cell epitopes of HIV-1 Tat protein have limited antigenic polymorphism in geographically diverse HIV-1 strains
|
Goldstein, Gideon
|
|
2001
|
19 |
13-14 |
p. 1738-1746
9 p.
|
artikel
|
| 32 |
Use of live bacterial vaccine vectors for antigen delivery: potential and limitations
|
Medina, Eva
|
|
2001
|
19 |
13-14 |
p. 1573-1580
8 p.
|
artikel
|
| 33 |
Vaccines for the developing world: current status and future directions
|
Wenger, Jay
|
|
2001
|
19 |
13-14 |
p. 1588-1591
4 p.
|
artikel
|
| 34 |
WHO expectation and industry goals
|
Vandersmissen, Walter
|
|
2001
|
19 |
13-14 |
p. 1611-1615
5 p.
|
artikel
|
Tijdschrift beschrijving